Key Points Johnson & Johnson has a rare and impressive streak of consecutive annual dividend increases. Merck is facing multiple challenges, but it is demonstrating that it can overcome them. 10 stocks we like better than Johnson & Johnson › Dividend investing will never go out of style. It's one of the best ways to take advantage of the magic of compounding (by reinvesting dividends), which can significantly boost long-term returns. And there is evidence that, over the past few decades, dividend-paying stocks have significantly outperformed non-dividend payers. But choosing a random income stock won't do -- they aren't all created equal.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.
